Boxer Capital, LLC
- SEC CIK
- 0001465837
- Latest filing
- Feb 14, 2025
Holdings in Q1 2024
Holdings as of Mar 31, 2024, filed May 15, 2024. Long positions only; changes compare share counts with Q4 2023.
- Positions
- 59
- +7 vs. Q4 2023
- Portfolio value
- $2.02B
- +$18.4M (+0.9%) vs. Q4 2023
| Security | Class | Shares | Value | % of portfolio | Share change | Action | History |
|---|---|---|---|---|---|---|---|
| SWTXSpringWorks Therapeutics, Inc. | COM | 3,421,541 | $168.4M | 8.3% | 00.0% | Unchanged | History |
| CYTKCytokinetics Inc | COM NEW | 2,100,000 | $147.2M | 7.3% | 00.0% | Unchanged | History |
| RVMDRevolution Medicines, Inc. | COM | 4,279,464 | $137.9M | 6.8% | 00.0% | Unchanged | History |
| TYRATyra Biosciences, Inc. | COM | 6,448,359 | $105.8M | 5.2% | 00.0% | Unchanged | History |
| APLSApellis Pharmaceuticals, Inc. | COM | 1,726,000 | $101.5M | 5.0% | 00.0% | Unchanged | History |
| IDYAIDEAYA Biosciences, Inc. | COM | 2,202,812 | $96.7M | 4.8% | 00.0% | Unchanged | History |
| MRUSMerus N.V. | COM | 1,900,000 | $85.6M | 4.2% | 00.0% | Unchanged | History |
| SRPTSarepta Therapeutics, Inc. | COM | 650,000 | $84.1M | 4.2% | 00.0% | Unchanged | History |
| NUVLNuvalent, Inc. | COM | 1,120,192 | $84.1M | 4.2% | 00.0% | Unchanged | History |
| ONCBeOne Medicines Ltd. | ADR | 500,000 | $78.2M | 3.9% | 00.0% | Unchanged | History |
| TNGXTango Therapeutics, Inc. | COM | 8,198,642 | $65.1M | 3.2% | 00.0% | Unchanged | History |
| NKTXNkarta, Inc. | COM | 5,607,350 | $60.6M | 3.0% | +4,167,350+289.4% | Added | History |
| FATEFate Therapeutics Inc | COM | 8,215,910 | $60.3M | 3.0% | +7,715,910+1,543.2% | Added | History |
| Avidity Biosciences, Inc.05370A108 | COM | 1,727,388 | $44.1M | 2.2% | +606,061+54.0% | Added | – |
| AKROAkero Therapeutics, Inc. | COM | 1,676,733 | $42.4M | 2.1% | 00.0% | Unchanged | History |
| RCKTRocket Pharmaceuticals, Inc. | COM | 1,466,051 | $39.5M | 2.0% | 00.0% | Unchanged | History |
| ARGXArgenx SE | SPONSORED ADR | 100,000 | $39.4M | 1.9% | −60,000−37.5% | Reduced | History |
| LEGNLegend Biotech Corp | SPONSORED ADS | 600,000 | $33.7M | 1.7% | 00.0% | Unchanged | History |
| AXSMAxsome Therapeutics, Inc. | COM | 400,000 | $31.9M | 1.6% | 00.0% | Unchanged | History |
| RCUSArcus Biosciences, Inc. | COM | 1,602,200 | $30.2M | 1.5% | 00.0% | Unchanged | History |
| ANABAnaptysbio, Inc | COM | 1,300,000 | $29.3M | 1.4% | 00.0% | Unchanged | History |
| IMVTImmunovant, Inc. | COM | 825,000 | $26.7M | 1.3% | −175,000−17.5% | Reduced | History |
| XENEXenon Pharmaceuticals Inc. | COM | 600,000 | $25.8M | 1.3% | 00.0% | Unchanged | History |
| ARVNArvinas, Inc. | COM | 608,614 | $25.1M | 1.2% | 00.0% | Unchanged | History |
| ITOSiTeos Therapeutics, Inc. | COM | 1,804,058 | $24.6M | 1.2% | 00.0% | Unchanged | History |
| VKTXViking Therapeutics, Inc. | COM | 300,000 | $24.6M | 1.2% | +300,000 | New | History |
| ORICOric Pharmaceuticals, Inc. | COM | 1,732,571 | $23.8M | 1.2% | 00.0% | Unchanged | History |
| KURAKura Oncology, Inc. | COM | 1,000,000 | $21.3M | 1.1% | +1,000,000 | New | History |
| GERNGeron Corp | COM | 6,000,000 | $19.8M | 1.0% | +3,000,000+100.0% | Added | History |
| DAWNDay One Biopharmaceuticals, Inc. | Stock | 1,189,943 | $19.7M | 1.0% | 00.0% | Unchanged | History |
| THRDThird Harmonic Bio, Inc. | COM | 2,000,000 | $18.9M | 0.9% | +1,250,000+166.7% | Added | History |
| KALVKalVista Pharmaceuticals, Inc. | COM | 1,590,000 | $18.9M | 0.9% | −60,000−3.6% | Reduced | History |
| ALLOAllogene Therapeutics, Inc. | COM | 3,850,000 | $17.2M | 0.8% | +3,850,000 | New | History |
| GPCRStructure Therapeutics Inc. | SPONSORED ADS | 400,000 | $17.1M | 0.8% | 00.0% | Unchanged | History |
| PRTAProthena Corp Public Ltd Co | SHS | 690,000 | $17.1M | 0.8% | +25,000+3.8% | Added | History |
| SANASana Biotechnology, Inc. | COM | 1,545,000 | $15.4M | 0.8% | +1,545,000 | New | History |
| RLAYRelay Therapeutics, Inc. | COM | 1,819,132 | $15.1M | 0.7% | 00.0% | Unchanged | History |
| PSTXPoseida Therapeutics, Inc. | COM | 4,475,000 | $14.3M | 0.7% | +4,475,000 | New | History |
| ENGNenGene Therapeutics Inc. | COM | 727,900 | $12.3M | 0.6% | +727,900 | New | History |
| PRLDPrelude Therapeutics Inc | COM | 2,568,287 | $12.2M | 0.6% | 00.0% | Unchanged | History |
| ELVNEnliven Therapeutics, Inc. | COM | 671,358 | $11.8M | 0.6% | +25,300+3.9% | Added | History |
| IOVAIovance Biotherapeutics, Inc. | COM | 750,000 | $11.1M | 0.5% | −650,000−46.4% | Reduced | History |
| JSPRJasper Therapeutics, Inc. | COM NEW | 350,000 | $10.3M | 0.5% | +350,000 | New | History |
| BOLDBoundless Bio, Inc. | COM | 711,329 | $10.1M | 0.5% | +711,329 | New | History |
| SYRESpyre Therapeutics, Inc. | COM NEW | 250,000 | $9.48M | 0.5% | 00.0% | Unchanged | History |
| IPSCCentury Therapeutics, Inc. | COM | 1,750,000 | $7.32M | 0.4% | +1,750,000 | New | History |
| ZNTLZentalis Pharmaceuticals, Inc. | COM | 450,000 | $7.09M | 0.4% | 00.0% | Unchanged | History |
| AMLXAmylyx Pharmaceuticals, Inc. | COM | 1,500,000 | $4.26M | 0.2% | +1,500,000 | New | History |
| ABSIAbsci Corp | COM | 700,000 | $3.98M | 0.2% | +700,000 | New | History |
| ATRAAtara Biotherapeutics, Inc. | COM | 4,150,000 | $2.88M | 0.1% | +4,150,000 | New | History |
| BDTXBlack Diamond Therapeutics, Inc. | COM | 506,000 | $2.57M | 0.1% | 00.0% | Unchanged | History |
| Direxion Shs ETF Tr25460G716 | DAILY S&P BIOTEC | 350,000 | $2.55M | 0.1% | +350,000 | New | – |
| BCABBioAtla, Inc. | COM | 686,347 | $2.36M | 0.1% | 00.0% | Unchanged | History |
| OBIOOrchestra BioMed Holdings, Inc. | COM | 238,193 | $1.26M | 0.1% | 00.0% | Unchanged | History |
| TARAProtara Therapeutics, Inc. | COM STK | 209,227 | $839.0K | <0.1% | 00.0% | Unchanged | History |
| MISTMilestone Pharmaceuticals Inc. | COM | 309,007 | $553.1K | <0.1% | 00.0% | Unchanged | History |
| DBVTDBV Technologies S.A. | SPONSORED ADR | 500,000 | $374.6K | <0.1% | 00.0% | Unchanged | History |
| Nuvation Bio Inc.67080N119 | *W EXP 07/07/202 | 266,666 | $80.7K | <0.1% | 00.0% | Unchanged | – |
| Surrozen, Inc.86889P117 | *W EXP 08/01/203 | 66,666 | $2.17K | <0.1% | 00.0% | Unchanged | – |
Sold out since Q4 2023 (6)
Positions held at the end of Q4 2023 that are gone from this filing.
| Security | Class | Shares in Q4 2023 | Value in Q4 2023 | % of portfolio in Q4 2023 | History |
|---|---|---|---|---|---|
| MRTXMirati Therapeutics, Inc. | COM | 3,201,440 | $188.1M | 9.4% | History |
| IMGNImmunoGen, Inc. | COM | 2,961,000 | $87.8M | 4.4% | History |
| KRTXKaruna Therapeutics, Inc. | COM | 250,000 | $79.1M | 3.9% | History |
| KODKodiak Sciences Inc. | COM | 600,000 | $1.82M | 0.1% | History |
| Rain Oncology Inc.75082Q105 | COM | 1,152,212 | $1.38M | 0.1% | – |
| BCELAtreca, Inc. | CL A COM | 2,202,333 | $290.7K | <0.1% | History |